In 2023, the total number of scientific publications in pharmaceutical science in Saudi Arabia stood at 379.71 units. The year-on-year variation from 2022 to 2023 was 5.79%, reflecting a consistent upward trend in recent years. Over the last two years, the annual growth has averaged 5.98%, showcasing a positive momentum in publications.
From 2013 to 2023, the compound annual growth rate (CAGR) was 23.16%, indicating a robust long-term growth trajectory. Notably, the industry experienced a significant surge in 2020, with a year-on-year increase of 113.15%, followed by steady growth in the subsequent years.
Looking ahead, the forecast suggests continued growth, with an average annual growth rate of 3.78% from 2024 to 2028. The expected total number of publications by 2028 is 482.01 units, representing a cumulative growth rate of 20.39% over the next five years.
Future Trends to Watch For:
- The increasing focus on research and development (R&D) investments by both government and private sectors in Saudi Arabia could accelerate the growth of pharmaceutical science publications.
- Collaborations with international research institutions and pharmaceutical companies might enhance the quality and quantity of research output.
- Advancements in technology and data analytics are expected to streamline research processes, potentially driving further growth in scientific publications.
